1. Fried MW, Shiffman ML, Reddy RK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.

2. Carithers RL Jr, Emerson SS. Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials. Hepatology. 1997;26(3 Suppl 1):83-88S.

3. Manns MP, McHutchison JG, Gordon SC,et al and the International Hepatitis Interventional Therapy Group. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial. Lancet. 2001;358(9286):958-965.

4. Lau DT, Kleiner DE, Ghany MG, et al. 10 years follow-up after interferon alfa therapy for chronic hepatitis C. Hepatology. 1998;28(4):1121-1127.

5. Imai Y, Kawata S, Tamura S, et al. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group. Ann Intern Med. 1998;129(2):94-99.

6. Schalm SW, Fattovich G, Brouwer JT. Therapy of hepatitis C: Patients with cirrhosis. Hepatology. 1997;26 (Suppl 1):128-132S.

7. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346(14):1074-1082.

8. Everson GT, Weinberg H. Living with Hepatitis C: A Survivor's Guide, 3rd Ed. Hatherleigh Press, Inc. New York, New York. 2001.

9. Shiffman ML, Di Bisceglie AM, Lindsay KL, et al. Peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 2004;126(4);1015-1023.

10. Cheng SJ, Bonis PA, Lau J, et al. Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: A meta-analysis of controlled and uncontrolled trials. Hepatology. 2001;33:231-240.

11. Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, et al. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Hepatology. 2001;33:704-707.

12. Everson GT, Folan R, Goff J, et al. The Colorado hepatitis treatment group: Early results of the use of combination interferon-alfa-2B (Intron A) plus ribavirin (Rebetrol) in the treatment of nonresponders. Hepatology. 1998; 476A (abstract).

13. Shiffman ML, Hofmann CM, Contos MJ, et al. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology. 1999;117(5):1164-1172.

14. Pestka SS. Langer JA, Zoon KC, Samual KC. Interferons and their actions. Annu Rev Biochem. 1987;56:727-777.

15. Fattovich G, Giustina G, Degos F, et al. Effectiveness of inteferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol. 1997;27(1):201-205.

16. Everson, GT. Maintenance interferon for chronic hepatitis C: More issues than answers? Hepatology. 2000;32(2):436-438.